Additionally, semaglutide has been shown to have a comparable risk profile to other GLP-1 RAs with respect to gastrointestinal adverse effects in the IBD population (106)
Mahmoud Salama Ahmed is a medicinal chemist at Texas Tech
Consensus-Based Guidance on Preoperative Management of Patients on GLP-1 Receptor Agonists
PMCID: PMC4404515 ) He L, Wang J, Ping F, Yang N, Huang J, Li Y, Xu L, Li W, Zhang H (2022) Association of glucagon-like peptide-1 receptor agonist use with risk of gallbladder and biliary diseases: a systematic review and meta-analysis of randomized clinical trials
Polycystic ovary syndrome (PCOS) is the leading cause of female infertility, according to the Mayo Clinic , and for women who have been prescribed semaglutide to combat the associated weight gain, the drug could improve their overall fertility